STUDY QUESTION: How does the duration of estrogen (E2) treatment prior to frozen-blastocyst transfers affect the live birth rate (LBR)?
Introduction
Advances in ART such as improvements in cryopreservation techniques or the current practice of 'elective single embryo transfer' have allowed for a great increase in the use of frozen embryo transfers over the last decade (Kupka et al., 2014) . Additionally, there is a trend toward deferred embryo transfer strategies that consist in cryopreservation of all embryos after a controlled ovarian stimulation with transfer of a thawed embryo in a subsequent cycle (Evans et al., 2014; Bourdon et al., 2017a) .
In order to promote favorable conditions for implantation before frozen-thawed embryo transfer (FET), various options ranging from reliance on the natural cycle, to ovarian stimulation or artificial endometrial preparation (AEP) (i.e. hormonal substitution with estrogen (E2) and progesterone) have proven to be effective to prepare the endometrium for implantation (Ghobara et al., 2017) . Several randomized controlled trials have compared different cycle regimens for FET, and no regimen has stood out as being superior to another (Ghobara and Vandekerckhove, 2008; Groenewoud et al., 2016) .
When AEP is used to optimize embryo-endometrium synchronization, E2 is supplied either orally and/or transdermally, from Day 1 of the menstrual cycle in which the embryo transfer will be performed. Several features of AEP remain to be clarified, such as the ideal duration, dosage or mode of administration of exogenous E2 (Madero et al., 2016) . Although in clinical practice the duration of E2 administration before FET differs for each woman, the upper limit for the duration of E2 priming has remained controversial. While some authors have assessed endometrial receptivity with different durations of E2 exposure in oocyte donation programs, the results on pregnancy rates were mixed (Navot et al., 1986; Remohí et al., 1995; Yaron et al., 1995; Michalas et al., 1996; Borini et al., 2001; Sunkara et al., 2011) . In addition, the optimal duration of E2 duration exposure as part of AEP before autologous blastocyst transfer has yet to be established.
The objective of this study was therefore to compare the effect of different lengths of E2 exposure on live birth rate (LBR) after frozenblastocyst transfer from autologous cycles.
Materials and Methods

Study population and inclusion criteria
We conducted an observational cohort study that included all single autologous frozen-thawed blastocyst transfers performed following AEP between July 2012 and December 2015 in the ART unit at the university-based reproductive medicine center of our institution, complying with the following inclusion criteria: (a) requirement for ART with IVF or ICSI, (b) age ≤42 years at the time of oocyte retrieval, (c) having a single autologous frozen-thawed blastocyst transfer and (d) endometrial preparation using AEP prior to ET whatever the ovulatory status was. Exclusion criteria were: (a) canceled embryo transfers, (b) FET derived from vitrified oocyte procedures, (c) embryo donation procedures, (d) natural endometrial preparation and (e) GnRH-agonist pre-treatment. Cycles with missing data and women lost to follow-up were secondarily excluded. We designed four groups according to the duration of E2 administration prior to embryo transfer: (i) ≤21 days (equal or less than 3 weeks), (ii) 22-28 days (4 weeks), (iii) 29-35 days (5 weeks) and (iv) 36-48 days (equal or more than 6 weeks). The '≤21 days' group' was considered as the reference group.
This study was approved by the National Data Protection Authority (Commission Nationale de l'Informatique et des Libertés, CNIL n°1 988293 v 0) on the fifth of September 2016.
Embryo culture, cryopreservation and thawing
Embryos were cultured at 37°C in an atmosphere of 5% CO 2 , 5% O 2 and 90% N 2 . Blastocysts were scored according to the grading system of Gardner and Schoolcraft (Gardner et al., 2002) and considered eligible for cryopreservation on Day 5 or Day 6 if they qualified as full (B3) or expanded (B4-5) blastocysts with a type A-C inner cell mass and/or a type A-C trophectoderm. Blastocysts with a type 'C' inner cell mass and a type 'C' trophectoderm were not cryopreserved regardless of their degree of expansion. A good-quality embryo was defined as a B3-B4 or a B5 embryo ≥ BB (AA, AB, BA, BB) (Gardner et al., 2002) .
The precise vitrification and thawing protocol has been reported in detail previously (Bourdon et al., 2017b) . Briefly, embryo vitrification was performed using closed Cryo-Bio-System vitrification High Security straws in combination with DMSO-EG-S as the cryoprotectants (Irvine Scientific© Freeze Kit). For thawing, the Irvine Scientific Thaw Kit was used.
Endometrial preparation prior to embryo transfer
Women received an E2 regimen that was delivered either transdermally (0.2 mg/day, simultaneously through two Vivelledot ® 100 systems, Novartis Pharma SA, Rueil-Malmaison, France) or orally (4 mg twice a day, Provames ® , Sanofi Aventis, Paris, France) from Day 1 of menstruation and continued for a minimum of 2 weeks, after which patients were examined in order to plan the embryo transfer. At Day 1 of menstruation, each woman called the ART-center in order to schedule an appointment for blood sample (progesterone level) and ultrasonography in order to evaluate the endometrium's thickness. The appointment's day was planned according to women's and center availabilities; knowing that a limited number of frozen embryo transfer per day can be managed by our laboratory unit. On this day, if endometrial thickness was lower than 6 mm or progesterone ≥1.5ng/l, embryo transfer was canceled. Thus, due to logistical concerns, estradiol length of administration could vary from 14 days to 48 days according to the available date for the embryo transfer. Endometrial thickness and progesterone levels were assessed the day before the progesterone administration so that time between this evaluation and the embryo transfer were identical for all patients. If conditions were appropriate (e.g. endometrium thickness ≥6 mm and progesterone <1.5 ng/ml), embryo transfer was performed on the fifth day of progesterone exposure. Vaginal progesterone treatment was initiated at a dose of 200 mg three times daily (Utrogestan ® , Besins international, Montrouge, France). Women who became pregnant by these procedures continued to be treated with progesterone and E2 at the same dose until 12 weeks of gestation.
Data analysis and statistics
The general characteristics of the patients were recorded prospectively during face-to-face interviews prior to the embryo transfer. The following data were collected: age at retrieval (years), smoking, BMI (weight (kg)/ [height (m)] 2 ), type of infertility (primary, secondary), number of previous IVF/ICSI cycles, Day 3 FSH, antral follicle count (AFC) and anti-Müllerian hormone (AMH), type of treatment (IVF or ICSI) and infertility causes (e.g. ovulation disorder, male factor, tubal factor, endometriosis, idiopathic, diminished ovarian reserve, or more than one etiology).
The primary outcome was LBR, which was defined as delivery of any viable infant at 22 weeks or more of gestation (Zegers-Hochschild et al., 2009) . Secondary outcomes included: Biochemical pregnancy, defined as a human chorionic gonadotropin serum level of more than 10 mU per milliliter (Chen et al., 2016) ; Clinical pregnancy rate (cPR) which was determined by ultrasonographic documentation of at least one fetus with a heartbeat at 6-7 weeks of gestation (Zegers-Hochschild et al., 2009); Early pregnancy loss, defined as a spontaneous pregnancy demise at less than 10 weeks of gestational age (Kolte et al., 2015) and obstetrical, delivery and neonatal outcomes. Standard definitions were used for gestational hypertension and pre-eclampsia (ACOG Committee on Practice Bulletins-Obstetrics, 2002). Gestational diabetes was defined as hyperglycemia first diagnosed during pregnancy, identified after a 75 g glucose load.
The delivery and neonatal outcomes were: gestational age at delivery, defined as preterm birth (<37 weeks of gestation (WG)) and post-term birth (>41 WG); low birth weight (<2500 g); high birth weight (≥4000 g), cesarean or vaginal delivery, and perinatal death (Barfield and Committee on Fetus and Newborn, 2011; Declercq et al., 2015) .
The Z-scores allow a measure to be compared with the expected measure based on a set reference value (Salomon et al., 2005) . It is determined using the formula: Z-score = (X GA − M GA )/SD GA where X GA is the value measured at a given gestational age, M GA is the expected value at this gestational age according to the reference chart, and SD GA is the SD of the expected value (Salomon et al., 2005) . Z-scores were determined after adjusting for gestational age and the child's gender.
All data were compiled into a digital database and analyzed using IBM Table SI ) and added in a multiple logistic regression model. Interactions between explanatory variables were tested 2 by 2. Included variables in the multiple model were those with a significance on univariate analysis at P < 0.10 or more and those that could potentially impact on live birth outcome (the route of estradiol administration (e.g. transdermal or per-os), the endometrial thickness and progesterone level (the day before progesterone administration)). We have also included the rank of embryo transfer in order to address the fact that some women received more than one embryo transfer during the study period. Correlation between variables was tested and if two variables were highly correlated, only one of them was introduced in the model. Backward stepwise selection was used to retain variables with a P-value of <0.05 in each final model. The parameter values for each of the final models were estimated by the maximum likelihood method. In case of significant differences, odds ratios (OR) and their 95% confidence intervals (95%CI) were calculated from the model's coefficients and their standard deviations.
Results
Study population
The process of our cohort selection is detailed in Figure 1 . Overall, 1377 blastocyst embryo transfers were analyzed in this study involving 852 women. During the study period, 336 women underwent more than one FET. FET were allocated to four groups according to the duration of the E2 exposure. (i) 330 FET were performed after 21 or fewer days of E2 treatment, (ii) 665 FET were performed after 22 to 28 days, (iii) 289 after 29 to 35 days and (iv) 93 formed after 36 to 48 days of E2 treatment.
Baseline characteristics
Patient characteristics are detailed in Table I . The mean number of previous IVF/ICSI cycles was slightly but significantly lower for the '≤21 days' group (1.41 ± 0.68) than for the '29 to 35 days' (1.69 ± 0.96) and '36 to 48 days' groups (1.68 ± 1.01) (P < 0.001). Endometrial thickness was slightly lower in '36 to 48 days' group (P < 0.001) and progesterone level on the day before the progesterone administration higher in '≤21 days' group (P < 0.001). However, in light of the study protocol, endometrial thickness was ≥6 mm and progesterone level was below 1.5 ng/ml prior to all FET. The proportion of anovulatory women was not significantly different between groups: 11(3.3%) in '≤ 21 Days', 29 (4.4%) in '22-28 Days', 14(4.8%) in '29-35 Days' and 7(7.5%) in '36-48 Days' (P = 0.366).
ART Outcomes
We found significant differences in LBR according to the duration of the E2 (Table II) . LBR significantly decreased in the '29 to 35 days' group (OR = 0.66; 0.46-0.95) and in the '36 to 48 days' group (OR = 0.49; 0.27-0.89), vs. the reference group. Differences between the four groups were not significant for biochemical pregnancy or cPR (Table II) . There was a significantly higher risk of early pregnancy losses for the '36 to 48 days' group (48.6%, OR = 2.37; 1.12-5.05) vs. the reference group (28.5%).
Variables independently associated with live birth: multivariate analysis
A multivariate analysis was performed to adjust for confounding factors (Table III) . The model included women's age (>35 y vs. ≤35 y), the number of previous ART cycles, the route of E2 administration (transdermal vs. per-os), the endometrial thickness, and progesterone level (on the day before progesterone administration), the embryo quality (good-quality embryo-as defined in the material section-vs. lower quality embryo), and the duration of E2 administration (in four groups). Offering the product of every possible pair of variables to the equation revealed no significant interaction. The variables with a significant impact on the LBR were maternal age 
Obstetrical, delivery and neonatal outcomes
The mean birth weight and Z-scores were significantly lower for the '36-48 days' group as compared to the reference group (3042 ± 801.2 g and −0.44 ± 1.50 vs. 3362 ± 602.9 g and 0.10 ± 0.94, respectively) (Table IV) . Other delivery and neonatal outcomes were comparable to what was found for the reference group (Table IV) . There was one neonatal death in the '≤21 days' group and one in the '22 to 28 days' groups.
Discussion
The aim of our study was to compare the effect of the duration of E2 exposure on reproductive outcomes. By univariate and multivariate analysis, our results found an association between durations of E2 exposure as part of AEP exceeding 28 days and a lower LBR.
To the best of our knowledge, our study is the largest (n = 1377) having examined the effect of the duration of E2 exposure prior to frozen-thawed autologous blastocyst transfers on the LBR. Our study's large sample size is likely to have partially reduced selection and statistical bias; In contrast with previous findings obtained with an oocyte donation program, by focusing on autologous blastocyst transfers, our approach improved external validity by taking into account the effects of maternal age, embryo quality, and several other factors that could negatively impact reproductive outcomes; Another strength of our study is that our results are applicable to daily clinical practice: E2 treatment duration shorter than four weeks would maximize chances of pregnancy and live birth. Lastly, numerous epidemiological variables were prospectively collected through face-to-face interviews prior to the ART.
Despite the precautions taken, our study may nonetheless be subject to certain shortcomings and/or biases. The present study suffers from the limitation of its design involving a retrospective analysis of a prospective cohort. In light of this context, great care was taken to minimize sources of bias, particularly through the use of a multivariate model and a large study sample size. Furthermore, some baseline characteristics differed between groups: The mean number of previous IVF/ICSI cycles was significantly lower for the '≤21 days' group than for the '29 to 35 days' and the '36 to 48 days' groups (P < 0.001). However, the logistic model demonstrated that this factor was not associated with LBR, showing that it had no impact on our results. The estradiol administration route (oral or transdermal) was also different between the groups. However, this factor has not been shown to impact on reproductive outcomes in the literature (Madero et al., 2016) . Moreover, in our multivariate model, it was not found to be associated with LBR. In addition, there was a significant difference between groups concerning the mean endometrial thickness. However, all women had an endometrial thickness between 6 and 18 mm and this factor was not found as a predictive factor for LBR after univariate and multivariate analysis. Given that some women have received more than one embryo transfer during the study period, to limit bias, we included in our multivariate model the rank of the embryo transfer. However, after multivariate analysis, this factor has no impact on our conclusion concerning the association between duration of E2 exposure and LBR, however few women had a high rank. Finally, we must insist on the fact that the choice for E2 administration duration was not related to women's or cycles characteristics, but only on the physical possibility of organizing the FET cycle, because of patients' availability or center overload. Thus, our findings are very likely due to the E2 administration duration and not to patients' characteristics, which is reinforced by the results of the multivariate model. Successful implantation depends in part on endometrial receptivity and synchronization between the embryo and the endometrium (Salamonsen et al., 2009) . Embryo implantation occurs during the 'window of implantation'. Estradiol and progesterone play a critical and fundamental role in establishment of receptivity (Young, 2013) . E2 is essential for endometrial proliferation and could be determinant for implantation, decidualization and early embryo development (Ramathal et al., 2010) . In animal models, it has been demonstrated that E2 also plays a crucial role in endometrial receptivity, by modifying endometrial Clinical pregnancy was defined as the observation of at least one fetus with a heartbeat at 6-7 weeks of gestation by ultrasonography. c Early pregnancy loss was defined as a spontaneous pregnancy demise prior to 10 weeks of gestational age. The embryo transfer rank following oocyte retrieval-the rank one is considered as the reference.
gene expression (Ma et al., 2003; Simon et al., 2003) . Ma et al, in a mouse model showed that high doses of exogenous E2 could switch the endometrium from a receptive state to a refractory state for implantation. A thorough control of E2 supply could turn out to be an important factor for improvement of female fertility in ART programs (Ma et al., 2003) . In human, in controlled ovarian stimulation followed by a fresh embryo transfer, it has been shown that high levels of E2 may be related to a higher implantation failure rate (Joo et al., 2010; Kutlu et al., 2016) . Several studies in oocyte donation models have demonstrated that a prolonged estrogen supplementation could be deleterious for implantation and pregnancy rates (Younis et al., 1992; Michalas et al., 1996) . Nevertheless, those prior studies regarding the impact of the duration of E2 exposure yielded mixed results concerning the optimal length of estrogen supplementation (Younis et al., 1992; Yaron et al., 1995; Michalas et al., 1996; Borini et al., 2001; Soares et al., 2005) . Younis et al. found that the pregnancy rate in oocyte donation programs was closely associated with the duration of estrogen stimulation. These authors concluded that, for optimal results, estrogen stimulation should be restricted to between 12 and 19 days (Younis et al., 1992) . Michalas et al. reported that the optimal duration of E2 exposure was 6-11 days before addition of progesterone, and that with longer exposures the pregnancy rate dropped significantly (Michalas et al., 1996) . By contrast, Yaron et al., Borini et al. and Soares et al. concluded that the duration of E2 treatment can be extended up to 5 weeks without causing a significant decrease in pregnancy rates (Yaron et al., 1995; Borini et al., 2001; Soares et al., 2005) . Interpreting these discrepancies is complex, due to the high level of heterogeneity in the study populations. All the mentioned reports above focused on oocyte donation programs. In addition, most of them evaluated relatively small groups of patients as compared to our series. Our results indicate that the length of estradiol treatment can be as long as 4 weeks without negative impact on the LBR. This wide interval allows flexibility in regard to scheduling of the embryo transfer. For clinicians, it requires careful planning and organization so as to schedule the embryo transfer in keeping with the patient's needs while also preserving optimal pregnancy rates.
For the first time, the present study suggests a link between the duration of E2 exposure prior to frozen-blastocyst transfer and the birth weight. With prolonged E2 exposure (i.e. 36-48 days) we found lower birth weights and lower Z-scores as compared to a duration of E2 exposure of less than 22 days. This suggests that prolonged supraphysiological exposure to estrogen prior to implantation may disturb decidualization processes and could influence placentation and therefore fetal growth as well. It is believed that estradiol plays a pivotal role in the development of the human endometrium, given that endometrial gene expression is controlled by a wide range of steroid receptors (Critchley et al., 2002; Driggers and Segars, 2002) . One can speculate that prolonged exposure to exogenous E2 may have a negative effect on endometrial gene expression profile. In a human transcriptomic approach focusing on recurrent implantation failures, endometrial preparation with AEP seemed to have a negative effect on the expression of genes and pathways that are crucial for endometrial receptivity as compared with a natural cycle (Altmäe et al., 2016 studied. In addition, the analysis of obstetrical delivery and neonatal outcomes in the current study needs to be interpreted with caution given that it involved a sample that only comprised a small number of subjects. Thus, larger and prospective studies are required to ascertain the impact of the duration of E2 exposure on birth weights.
Conclusion
Based on our findings, the duration of E2 administration exceeding 28 days decreases the LBR after autologous frozen-thawed blastocyst transfer as compared to duration of E2 administration shorter than 21 days. After ethics review, prospective randomized studies could be processed to fully substantiate our findings.
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